Keywords: update, blow, aventis/genta, fda, says, data, genasense

UPDATE: Blow for Aventis/Genta as FDA says data on Genasense not adequate

Article | 10 May 2004

Print This

The US Food and Drug Administration's Oncologic Drugs Advisory Committee has said that, with no evidence of increased survival shown ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in